MDPI and ACS Style

Maggio, A.; Mastroianno, S.; Di Stolfo, G.; Castellana, S.; Palumbo, P.; Leone, M.P.; Spirito, A.; Potenza, D.R.; Ladogana, S.; Castori, M.; Carella, M.; Villella, M.; Salvatori, M.P. Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation. Cardiogenetics 2022, 12, 80-88. https://doi.org/10.3390/cardiogenetics12010007

Maggio A, Mastroianno S, Di Stolfo G, Castellana S, Palumbo P, Leone MP, Spirito A, Potenza DR, Ladogana S, Castori M, Carella M, Villella M, Salvatori MP. Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation. Cardiogenetics. 2022; 12(1):80-88. https://doi.org/10.3390/cardiogenetics12010007

Maggio, Angela, Sandra Mastroianno, Giuseppe Di Stolfo, Stefano Castellana, Pietro Palumbo, Maria P. Leone, Anita Spirito, Domenico R. Potenza, Saverio Ladogana, Marco Castori, Massimo Carella, Massimo Villella, and Mauro P. Salvatori. 2022. "Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation" Cardiogenetics 12, no. 1: 80-88. https://doi.org/10.3390/cardiogenetics12010007